BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Press Releases

  MetasTx Secures NCI Grant to Enable the Advancement of Dual-Track Strategy Against Metastatic Prostate Cancer

  June 26, 2025

   · 

  3 min read
• Press Releases

  Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

  June 26, 2025

   · 

  5 min read
• Press Releases

  Quest Diagnostics Releases 2024 Corporate Responsibility Report

  June 26, 2025

   · 

  3 min read
• Press Releases

  Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine

  June 26, 2025

   · 

  2 min read
• Press Releases

  Transcenta Strengthens Promise for Osemitamab (TST001) for G/GEJ Cancer with OS Data from First-Line Triple Combo Trial

  Key Efficacy Outcomes l Median overall survival (mOS) was 20.4 months in all 82 patients enrolled. l In 26 patients with CLDN18.2 expression ≥40% (2+ intensity) and known PD-L1 CPS, mOS reached 21.7 months, mPFS 16.6 months, cORR 68%, and mDoR 16.5 months at a 22.6-month median follow-up.

  June 26, 2025

   · 

  1 min read
• Press Releases

  Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

  June 26, 2025

   · 

  3 min read
• Press Releases

  HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025

  June 26, 2025

   · 

  3 min read
• Press Releases

  Sun Pharma Announces Appointment of Richard Ascroft as CEO North America

  June 26, 2025

   · 

  3 min read
• Press Releases

  New ACS Cancer Atlas: Global Report Shows Nearly Half of Cancer Mortality Worldwide Attributable to Potentially Modifiable Risk Factors

  June 26, 2025

   · 

  5 min read
• Press Releases

  GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent

  June 26, 2025

   · 

  5 min read